ライフサイエンスコーパス: Pap smear

1 th high-grade SIL on colposcopy and referral Pap smear.

2 ening mammography, and 77% reported a recent Pap smear.

3 the impact of screening measures such as the Pap smear.

4 age of women with atypical squamous cells on Pap smear.

5 supplements the information provided by the Pap smear.

6 ol for the direct detection of TERC gains in Pap smears.

7 defined as at least three consecutive normal Pap smears.

8 acy is presented using liquid-based cytology Pap smears.

9 g approximately 81,000 mammograms and 35,000 Pap smears.

10 igh-risk HPV cervical infection had abnormal Pap smears.

11 from screening mammography or Papanicolaou (Pap) smears.

12 001), and have undergone cancer screening by Pap smear (67.3% v 54.8%, P<.0001), mammogram (80.4% v 7

13 cificity (0.43 versus 0.93) for detection of Pap smear abnormalities, compared to Hybrid Capture.

14 3% [-8% to 45%]) among those who had >/= one Pap smear after enrollment.

15 se may decrease the number of false-negative Pap smears and are an option for laboratories.

16 eviously stained Pap smears for which repeat Pap smears and clinical follow-up were available.

17 Screening with Pap smears and mammography was assessed by questionnaire

18 screened for cervical and breast cancer with Pap smears and mammography, even after adjustment for ot

19 the new Bethesda System for the reporting of Pap smears and the new guidelines for the management of

20 rrespondence between microscopic findings of Pap smears and the vaginal microbiota composition determ

21 participant received a vaginal examination, PAP smear, and completed a questionnaire.

22 Rates of recent screening mammography and Pap smears are high among older women in California.

23 wareness towards breast cancer, knowledge of Pap smear, breast self-exam, breast clinical exam, and h

24 0.001, 95% CI: 2.3, 9.5), and engagement in Pap smear by 3.5 percentage points (p = 0.004, 95% CI: 1

25 dence Interval [CI]: 1.0, 8.5), awareness of Pap smear by 5.9 percentage points (p = 0.001, 95% CI: 2

26 uidelines for the management of the abnormal Pap smear by the American Society of Colposcopy and Cerv

27 Rescreening of Pap smears by PAPNET, followed by reevaluation of abnorm

28 amplification of TERC in routinely collected Pap smears can assist in identifying low-grade lesions w

29 Pap smears, cervical tissues, and HPV/DNA specimens were

30 ortion of these women who reported a current Pap smear did not change during the 10-year study period

31 s after the recommendation), 69.1% had had a Pap smear during the same period (P value for the compar

32 cal examination findings, anal Papanicolaou (Pap) smear findings.

33 obe set to a series of 59 previously stained Pap smears for which repeat Pap smears and clinical foll

34 aging was performed at one wavenumber on the Pap smears from patients with specimens negative for int

35 essed spontaneously (regressors), and normal Pap smears from women who subsequently developed CIN3 or

36 ain was found in 33% of cytologically normal Pap smears from women who were diagnosed with CIN3 or in

37 reening for cervical abnormalities using the Pap smear has achieved a substantial reduction in morbid

38 fficient cervical cancer classification from Pap-smear images.

39 ferred for colposcopy because of an abnormal Pap smear in cervical-cancer screening can be treated by

40 areer related to the medical field, or had a Pap smear in the last three years tend to have higher kn

41 undergone hysterectomy reported having had a Pap smear in the past 3 years; in 2002 (6 years after th

42 (78%) than normal-weight women (84%) had had Pap smears in the previous 3 years (P < 0.001).

43 The risk of an abnormal Pap smear increased with persistent HPV infection, parti

44 breast clinical exam, and having received a Pap smear is extracted from the Lesotho Demographic and

45 Cervical cancer screening using the Pap smear is limited by invasive sampling and low partic

46 The introduction of liquid Pap smear methods using exfoliated cervical cells presen

47 h men >/= 5 years older, history of abnormal PAP smear, older age, and living separately from parents

48 ta, reassuring gynaecologists for the use of Pap smear or wet mount microscopy for rapid evaluation o

49 ram/X-ray (OR = 1.27, 95% CI = 1.16-1.39) or pap smear (OR = 1.16, 95% CI = 1.06-1.28), and males wer

50 ispanic females less likely to have a recent Pap smear (OR, 0.7; 95% CI, 0.5 to 1.0); black and Hispa

51 plasma levels were associated with abnormal Pap smears (P=.01; relative risk, 2.11).

52 The conventional Pap-smear procedure is accurate but subject to human err

53 The repeat Pap smear result was abnormal in 76.2% (95% CI, 63.5%-85

54 At screening visits only HPV test and Pap smear samples were collected, and at biopsy visits c

55 Ninety-four Pap smear samples with a cytological diagnosis of ASCUS

56 patients tested by clinical human biopsy or pap smear samples.

57 DNA from cervical cells, collected with the Pap smear sampling method, was spiked with HPV-16 DNA an

58 Many US women are undergoing Pap smear screening even though they are not at risk of

59 research has focused on new technologies for Pap smear screening such as thin layer technology, the a

60 Force recommended that routine Papanicolaou (Pap) smear screening is unnecessary for these women.

61 s were compared: (1) maintaining the current Pap-smear screening strategy combined with vaccination;

62 V) DNA testing of women having Papanicolaou (Pap) smears showing atypical squamous cells of undetermi

63 ver, results to date suggest that thin layer Pap smear technology may improve sensitivity in the dete

64 n reduce the high false-negative rate of the Pap smear test and may facilitate mass automated screeni

65 patients with positive result from standard Pap smear test, indicating that an electrochemical immun

66 least costly option, which retained current Pap-smear testing alongside vaccination, reduced cervica

67 only 17% of all women aged 35-60 undergoing Pap-smear testing.

68 Papanicolaou (Pap) smear tests have reduced mortality by up to 70%.

69 After accounting for Pap smears that may have preceded a recent hysterectomy

70 zed image analysis to rescreen Papanicolaou (Pap) smears that have already been examined by cytotechn

71 Pap smears were obtained annually.

72 Cervical lavage samples and Pap smears were obtained from 284 women in Malawi to eva

73 ecialty, rate differences for screening with Pap smears were still seen among overweight (-3.5% [95%

74 e discriminated between normal and cancerous Pap smears with 100% accuracy.

75 within the previous 2 years and a screening Pap smear within 3 years.

76 story of hysterectomy who reported a current Pap smear (within 3 years).